The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26004580 |
5 |
An unprecedented dual antagonist and agonist of human Transglutaminase 2. |
Stanford University |
26005023 |
25 |
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors. |
University of Leeds |
24432384 |
7 |
Tissue transglutaminase: an emerging target for therapy and imaging. |
TBA |
23835447 |
32 |
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors. |
Aston University |
22224594 |
346 |
Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease. |
Evotec (Uk) |
24900424 |
60 |
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. |
TBA |
24900540 |
47 |
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease. |
TBA |
21215619 |
114 |
Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2. |
Stanford University |
17948018 |
17 |
Mechanisms, biology and inhibitors of deubiquitinating enzymes. |
Institute For Bio-Medical Research |
17590341 |
3 |
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2. |
Stanford University |
17149878 |
15 |
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles. |
Stanford University |
15780627 |
61 |
Structure-activity relationship study of novel tissue transglutaminase inhibitors. |
Harvard Medical School |
29664627 |
46 |
N |
Helmholtz-Zentrum Dresden-Rossendorf |
28810189 |
11 |
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease. |
Alma Mater Studiorum-University of Bologna |
28122456 |
4 |
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors. |
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif) |
28858494 |
30 |
Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase. |
University of Ottawa |